FIGURE 6 - uploaded by Mark Kidd
Content may be subject to copyright.
Nicholas Senn (bottom left) (1844 Y 1908) of Chicago contributed significantly to the elucidation of pancreatic function and disease. He used skillful laboratory experimentation and clinical observation not only addressing the mechanisms of acute pancreatitis but also providing rational insight into the validity of surgical techniques for its treatment. As such, he was especially responsible for bringing the dangers of pancreatic surgery and the diseases of the pancreas to the attention of US surgeons.
Source publication
Among the various pancreatic disorders, the pace of scientific discovery in acute pancreatitis has been particularly slow. The objective of this paper was to briefly review the history of scientific discovery of the clinical features, pathophysiology, and treatment of acute pancreatitis. A clinical description of acute pancreatitis was first presen...
Context in source publication
Context 1
... by Reginald Fitz (1843 Y 1913), who thought the origin was bacterial infection and H. D. Rolleston who proposed it to be a solar plexus Y related event. Robert Langerhans postulated that it was pancreatic ferment that resulted in necrosis of fat tissue, and Simon Flexner, in 1897, suggested that this ferment was lipase. In a seminal article published in 1889, Reginald Fitz of Boston presented the first systematic analyses of acute pancreatitis (Fig. 5). 28 Fitz was born in Chelsea, Mass, and entered Harvard College in 1858 but left in his junior year to work in a copper mine. 39 He returned in 1862 to complete BA and MD degrees and then proceeded to Europe, where he acquired a unique blend of training in both clinical medicine and pathology under the guidance of such illustrious scientists as Rokitansky, Skoda, and Billroth. Fitz also worked in the laboratory of Rudolf Virchow (1821 Y 1902), where he became an expert in micros- copy and also brought to the United States Virchow’s teaching that disease is an expression of aberration in normal cellular function. Having returned to Massachusetts, as an instructor in Pathology and later as Shattuck Professor of Pathologic Anatomy, he pioneered integration of clinical information with pathologic findings, and his perspicacity led to significant advances in surgical pathology including characterization of acute appendicitis, intestinal obstruction, complications of Meckel diverticulum, and acute pancreatitis. In 1889, at the New York Pathological Society’s Middleton- Goldsmith lecture, Fitz presented his article entitled B Acute Pancreatitis: A Consideration of Hemorrhage, Hemorrhagic, Suppurative, and Gangrenous Pancreatitis, and of Disseminated Fat Necrosis [ in which he systematically reviewed the clinical symptoms in 53 cases of pathologically documented acute pancreatitis. 28 In addition, he detailed the various hemorrhagic, suppurative, and gangrenous changes in acute pancreatitis and their pathological differentiation. He further commented on various etiologies such as gall stones, alcohol, perforating gastric ulcer, and trauma. Quite remarkably, Fitz also described pancreatic abscess, splenic vein thrombosis, and a likely pseudocyst of the pancreas as associated complications of acute pancreatitis. In this paper, Fitz also proposed a relationship between pancreatic hemorrhage and pancreatitis and a causal link between disseminated fat necrosis and acute pancreatitis. By his systematic analysis of the various facets of acute pancreatitis, Fitz laid the foundation for antemortem diagnosis of this disease and greatly facilitated subsequent pancreatic research at the turn of the 20th century. Interestingly, Fitz initially advocated a conservative approach to the surgical management of patients with acute pancreatitis, noting that B an operation I in the early stages of this disease, is extremely hazardous. [ 40 However, his recommendation later changed to early laparotomy as performed for other causes of acute abdomen. Despite the accumulating knowledge on pancreatitis, it was not until the middle of the 20th century that an understanding of the differences between acute and chronic pancreatitis was appreciated. However, there were multiple descriptions of pancreatic concretions in the 18th and 19th centuries. In 1678, de Graaf recounted previous reports of pancreatic stones by his contemporaries. After this, there were also numerous reports of pancreatic lithiasis at the time of autopsy by various authors including Bonet, Morgagni, and Johann Friedrich Meckel (1724 Y 1774). 5 In 1799, Matthew Baillie (1761 Y 1823) of London published plates that clearly depicted pancreatic ductal concretions, ductal dilatation, and changes of chronic pancreatitis. 41 At the turn of the 19th century, Sir Arthur Mayo Robson (1853 Y 1933) of Leeds presumed the etiology to be of bacterial infection; however, the distinction among acute, subacute, and chronic was still controversial. 42,43 In 1946, Comfort, 44 at the Mayo Clinic, provided a significant analysis of the clinical entity of chronic pancreatitis and, in so doing, produced the seminal manuscript on the subject that has, for 50 years, remained the critical commentary on the disease. One of the contemporaries of Reginald Fitz who contributed extensively to the advancement of our knowledge of the pancreas was Nicholas Senn (1844 Y 1908), a surgeon who was born in Sweden but later moved to the United States and attended the Chicago Medical School. 5 He initially worked at the Cook County Hospital in Chicago and Milwaukee (Wis- consin) Hospital before proceeding to Munich for further training in surgery before finally returning to Rush Medical College as professor of surgery. In 1886, Senn presented an extensive account of his surgical experiments on the pancreas at the meeting of the American Surgical Association as an article entitled B Surgery of the pancreas, as based upon experiments and clinical re- searches [ (Fig. 6). 5,45 Starting with a review of the available surgical literature on the pancreas, Senn noted that the only operations available were either excision of retention cysts or formation of external pancreatic fistulas to drain such cysts. 45 He detailed a series of animal experiments, of which one was transection of the pancreas followed by suturing to prevent hemorrhage. In this experiment, Senn concluded that the con- tiguous portion of the pancreas continued to secrete digestive juices and that extravasation of the pancreatic juice from the distal end of the gland into peritoneum did not have adverse consequences. He also disproved the prevailing notion of dead pancreatic tissue being a highly putrescible substance leading to infection by crushing a segment of the pancreatic glands of 2 cats under aseptic conditions. He concluded that the affected part of the gland is absorbed and replaced by connective tissue while the rest of the gland functions normally. Presciently, he also noted that if the outlet of the pancreas is affected, it leads to ductal obstruction from scarring and destruction of the gland. His other experiments dealt with partial and total pancreatectomy, effects of the introduction of pancreatic juice into the peritoneal cavity, and the circulation, pancreatic fistulae, and gangrene of the pancreas. His observations on total pancreatectomy led him to caution against this operation because it could lead to B damage or necrosis of the duodenum. [ Senn recommended operative debridement of the gangrenous pancreas ex- trapolating case reports, which noted spontaneous recovery from gangrene of the pancreas by sloughing of the gland through the duodenum. Indeed, his experiments laid the foundation for future experimental work in pancreatic diseases, provided guiding principles for pancreatic surgery, and led him to being recognized as the father of experimental pancreatology. 5 In 1896, Hans Chiari invoked a role for pancreatic enzymes in the pathogenesis of pancreatic necrosis and proposed a theory of tryptic autodigestion initiated by activation by bile as initially proposed by Claude Bernard or alternatively by enterokinase as had been suggested by Nicholas Petrovich Shepovalnikov 3,46 in 1889. Gerhard Katsch (1887 Y 1961), in 1939, expanded this concept based on Heidenhein’s original 1875 recognition of the inactive forms of enzymes in pancreatic cells. He described the phenomenon of Fermentengleisung (derailment of enzymes) whereby circulating activated pancreatic enzymes resulted in damage to the lungs, kidneys, and capillaries. Similar explanations for hypocalcemia, fat necrosis, capillary permeability, pulmonary surfactant damage, and myocardial depression were considered by a variety of investigators 5 between 1944 and 1970. None has proved to be more persuasive than the role of superimposed infection that Sir Berkeley Moynihan (1856 Y 1936) 47 had empha- sized as early as 1925. Despite nearly a century of inquiry into the mysteries of the cataclysmic cascade of pancreatic enzyme activation, the key initiating factors and the subsequent mechanisms of glandular damage as well as the varied pathophysiological consequences of acute pancreatic inflammation are still poorly understood. The principal factor that leads to pancreatic injury is believed to be pathological activation of intracellular digestive enzymes, possibly as a result of colocalization of pancreatic zymogens with lysosomal enzymes to produce active trypsin. 48 Disruption of the pancreatic acinar cell membrane is also postulated as a key initiating event in the pathogenesis of acute pancreatitis. 49 Recent work has highlighted the role of disruption of protective mechanisms such as specific trypsin inhibitors (eg, serine pro- tease inhibitor Kazal type 1), compartmentalization of enzymes, and low intracellular Ca 2+ concentrations, which prevent pathologic activation of trypsinogen. 50 In addition, the down- stream enzymatic, inflammatory, and cell death pathways and the consequent activation of the systemic inflammatory response syndrome in severe acute pancreatitis have received considerable attention, especially with regard to the extrapancreatic facets of the disease. However, contemporary understanding of the pathogenesis is mostly derived from animal models and at the present time, the degree to which these models reflect human disease remains limited. 51 Although these advances have greatly enhanced the management of patients with severe acute pancreatitis, targeted therapeutic modalities that prevent or limit the degree of inflammation have not come to fruition. Up until the mid 20th century, it was not appreciated that acute pancreatitis was a disease with multiple etiologies that required different approaches for diagnosis and treatment. Now, gallstones are considered to be responsible for 35% to 40% of cases of acute pancreatitis, and alcohol is an etiologic factor in approximately 30% of acute attacks of ...
Citations
... with AP, gallstones and alcohol are the two most common etiologic factors, accounting for up to 80% of all cases. 2,3 The exact pathogenesis of AP is still unknown, and several treatment options have been proposed. The most widely accepted is the uncontrolled release and intraductal activation of trypsin and the lack of adequate trypsin clearance, leading to pancreatic inflammation and subsequent initiation of the inflammatory cascade, which in turn triggers AP. 4 Leukocyte activation and migration is the key determinant of local and systemic complications in AP. 4,5 Several strategies are currently used to assess severity and predict outcome. ...
Background: Acute abdominal discomfort is a common symptom of acute pancreatitis (AP). However, because most clinics are unable to rapidly monitor pancreatic enzymes, early detection of AP is challenging. Therefore, the purpose of this study is to investigate the utility of serial urine trypsinogen-2 measurement as a prognostic indicator in individuals with AP. Methods: A total of 60 patients with AP who presented to the surgical emergency department within 72 hours of symptom onset were included in the study, regardless of sex or age. AP was classified into mild, moderate and severe according to the revised Atlanta classification. Patient’s urine samples were collected at admission, day 3, day 5, and day 7 for determination of urine trypsinogen-2 level. Results: The mean value of S. amylase (IU/l), S. lipase (IU/l), C-reactive protein (CRP) (mg/l), and urinary trypsinogen 2 were increased in severe compared with mild AP. The mean value of urinary trypsinogen 2 was significantly decreased from day 1 to day 7 after treatment in the mild, moderate, and severe AP groups. With these cut-off values, urinary trypsinogen 2 had a sensitivity of 92.3%, specificity of 42.9%, positive productive value (PPV) of 75%, and negative productive value (NPV) of 75% for diagnosing the severity of AP. These tests demonstrate the accuracy of urinary trypsinogen-2 to determine severity of AP. Conclusions: In a cross-sectional study, urinary trypsinogen-2 can be used as both diagnostic and prognostic indicator for AP.
... [10] During this time, considerable progress has been made; Claude Bernard initially demonstrated fat necrosis in dogs in 1856; Reginald Fitz first described hemorrhagic, suppurative, and gangrenous changes in AP in 1889; and Hans Chiari unveiled the role of pancreatic enzymes in the pathogenesis of pancreatic necrosis in 1896. [11] In the 21 st century, research on the molecular mechanisms of AP (calcium-mediated injury, unfolded protein response, autophagy, and unsaturated fatty acids impact, etc) has brought hope for a novel molecular targeted therapy in AP treatment. [12] Meantime, many large cohort studies have been conducted in the general population, and comprehensive systematic literature reviews on the prognosis and outcomes of AP and optimized treatment strategies for AP have been published. ...
Acute pancreatitis (AP) is a common digestive disease encountered in Emergency Departments that carries a heavy socioeconomic burden. This study was conducted to determine the global status of AP research. Articles related to AP published in 1999 to 2018 were retrieved from the Web of Science (WOS) database and the 20 highest-output countries or regions were determined based on the total number of publications. Correlation analysis of AP research output and the gross domestic product (GDP) of each country or region was conducted. The quantity and quality of research of these 20 highest-output countries were compared to the total output, outputs per capita, and average impact factor (IF). All annual data were analyzed using time-trend analysis. A keyword co-occurrence analysis was conducted to determine the highlights in AP research. In total, 17,698 publications were retrieved, and 16,461 papers (93.0%) of them were from the 20 highest-output countries. A significantly positive correlation was identified between AP research output and the GDP (R = 0.973, P < .001). The 5 highest-output countries were the USA (24.9%), China (12.3%), Germany (7.5%), Japan (6.7%), and the UK (6.1%). Finland ranked 1st in the number of publication per capita, the USA had the highest accumulated IF (25,432.758) and total citations (104,592), Switzerland had the highest average IF (6.723), and Netherland had the highest average citations (51.90). Genetic research and AP-related hyperglycemia were research highlights. Analysis of the global output of research of AP research showed signs of growth. Research output was positively correlated with GDP. For the most productive countries, research quality was stable. Although developing countries lagged behind in output per capita and quality, great progress has been made in the past 2 decades.
... When chronic pancreatitis sets in, it usually causes steatorrhea and weight loss. A Dutch anatomist Nicholas Tulp, [8] first reported acute pancreatitis in 1652, later in 1889. Its diagnosis was established by specifying its signs and symptoms by a Harvard pathologist, Reginald Fitz. ...
Drug-induced pancreatitis is one of the rare causes of pancreatitis. Identification of the cause of pancreatitis is vital to prevent reintroduction and subsequent recurrence of the disease. A 32-year-old male, a known case of chronic kidney disease on maintenance hemodialysis, presented with a history of fever for three months. He was diagnosed with tuberculosis clinically after ruling out all possible causes of pyrexia of unknown origin, considering the endemicity and clinical picture. He was started on antitubercular drugs, following which, two weeks later, he developed acute pancreatitis. Pancreatitis was resolved following the cessation of the drugs. The etiological factor of acute pancreatitis should always be identified. In patients who have been recently introduced to antitubercular drugs, a possibility of drug-induced pancreatitis should be kept after the common causes have been excluded. It is especially crucial to identify the cause of pancreatitis to prevent recurrence of pancreatitis; subsequently, its complications and, most importantly, the withdrawal of the drug has an excellent prognosis in patients with drug-induced acute pancreatitis. The causative drug should be stopped and never reintroduced.
... Pancreatitis, the inflammatory disorder of the pancreas, is characterized by moderate to severe abdominal pain, nausea, vomiting, indigestion, weight loss and steatorrhea, affecting individual's personal, professional and social life [1]. The first case of Acute Pancreatitis (AP) was reported in year 1652 by Dutch anatomist Nicholas Tulp [2]. Later, Reginald Fitz, a pathologist from Harvard, in 1889, established the diagnosis of Acute Pancreatitis by specifying its signs and symptoms [3]. ...
Changing Demography of Pancreatitis Patients in India
... 100CE), to describe an organ that had no cartilage or bone. Despite its early roots, it was not until much later that the first clinical description of acute pancreatitis by Nicholaes Tulp (1593-1674), a Dutch anatomist, was published [1]. However, amidst much speculation of causality, the first systematic assessment of acute pancreatitis was authored by Reginald Fitz in his entitled review "Acute Pancreatitis: A Consideration of Hemorrhage, Hemorrhagic, Suppurative, and Gangrenous Pancreatitis, and of Disseminated Fat Necrosis," highlighting alcohol, gallstones, and other etiologic factors. ...
Acute pancreatitis represents a disorder characterized by acute necroinflammatory changes of the pancreas and is histologically characterized by acinar cell destruction. Diagnosed clinically with the Revised Atlanta Criteria, and with alcohol and cholelithiasis/choledocholithiasis as the two most prominent antecedents, acute pancreatitis ranks first amongst gastrointestinal diagnoses requiring admission and 21st amongst all diagnoses requiring hospitalization with estimated costs approximating 2.6 billion dollars annually. Complications arising from acute pancreatitis follow a progression from pancreatic/peripancreatic fluid collections to pseudocysts and from pancreatic/peripancreatic necrosis to walled-off necrosis that typically occur over the course of a 4-week interval. Treatment relies heavily on fluid resuscitation and nutrition with advanced endoscopic techniques and cholecystectomy utilized in the setting of gallstone pancreatitis. When necessity dictates a drainage procedure (persistent abdominal pain, gastric or duodenal outlet obstruction, biliary obstruction, and infection), an endoscopic ultrasound with advanced endoscopic techniques and technology rather than surgical intervention is increasingly being utilized to manage symptomatic pseudocysts and walled-off pancreatic necrosis by performing a cystogastrostomy.
... У даний час усе більшу увагу дослідників і практичних лікарів-хірургів привертає проблема діагностики та лікування гострого панкреатиту. Це обумовлено тим, що за останні роки гострий панкреатит вийшов на третє місце в структурі гострої хірургічної патології, при цьому перше та друге місце займають такі захворювання, як апендицит і холецистит [3]. ...
The aim of the work was to study the dynamics of changes in the immune system indices and antioxidant protection when fluoroquinolones are included in the treatment regimen for acute edematous pancreatitis. The study included 86 patients with a diagnosis of acute edematous pancreatitis. Group I (n=40) consisted of patients who received treatment according to national and local standards and protocols, group II (n=46) — patients who additionally received fluoroquinolones as part of a comprehensive treatment. The control group consisted of 48 conditionally healthy people in whom laboratory and instrumental diagnostics were carried out similarly to those in patients with acute pancreatitis. According to the purpose and objectives of the study, the state of the immune system and the antioxidant defense system was studied. In patients with acute pancreatitis, changes in the indicators of the immune status were revealed, manifested by the formation of a secondary immunodeficiency with the addition of an autoimmune component. The traditional scheme of pharmacotherapy of acute pancreatitis without the use of antibiotics made it possible to partially correct the indicators of immune status. The use of ciprofloxacin in the complex pharmacotherapy of acute pancreatitis contributed to the normalization of the studied parameters. Thus, the use of fluoroquinolones in the complex pharmacotherapy of acute pancreatitis made it possible to effectively normalize the state of the immune system, cytokine and antioxidant statuses.
... The descriptions however varied and clearly, these early reports on pancreatitis did not discriminate between AP and chronic pancreatitis. 2 Interestingly, nearly four centuries later the precise mechanisms of AP remain unknown and treatment modalities are still of a supportive nature, rather than specific to the pancreatic inflammation. 3 The pancreas gland has both an endocrine and an exocrine part. ...
Endoscopic retrograde cholangiopancreatography (ERCP) is the most commonly used treatment for patients with disorders of the bile ducts and pancreas. More than 6,000 procedures are annually performed in Denmark. The procedure is associated with a 5-15% risk of subsequent acute inflammation of the pancreas entitled post-ERCP pancreatitis (PEP). Pancreatitis is a serious condition which can cause prolonged severe disease, chronic pancreatitis and death. Pancreatitis is an inflammatory condition that cannot be specifically treated neither medically nor surgically. The current thesis evaluated means of preventing PEP and the potential long-term consequences.
Study I was a cohort-study on the effect of implementing a one-time, peri-procedural administration of a 100 mg suppository diclofenac for the prevention of PEP. A total of 400 patients undergoing ERCP were included of which 182 received diclofenac. In both uni- and multivariable analysis diclofenac was associated with a reduced incidence of PEP, moderate to severe PEP, and elevated serum-amylase. In multivariable analyses with adjustment for potential confounders, diclofenac was associated with a reduced overall incidence of PEP with 65%.
Study II was a cohort study evaluating the influence of patient body-weight on the effect of 100 mg diclofenac for the prevention of PEP. A total of 772 patients were included of whom 77 (10%) patients developed PEP. Diclofenac was administered in 378 (49%) patients and 394 (51%) patients received no prophylaxis. Patient body weight was significantly associated with the development of PEP in the group of patients who received diclofenac but not in the group of patients who did not. In multivariable regression analysis, increasing patient body weight was inversely associated with the incidence of PEP in patients who received 100 mg of diclofenac for the prevention of PEP.
Study III was a narrative review on how to prevent PEP. Effective strategies for preventing PEP were reviewed and evaluated and the review provides a clinically applicable approach to PEP-prevention in the pre-, peri-, and post-ERCP setting. Patient selection, risk stratification, procedural techniques, and a multi-modal approach to PEP-prophylaxis were described and discussed. Furthermore, ongoing and future research initiatives were debated and an easy-to-use, clinically applicable figure on the prevention of PEP was presented.
Study IV and V were controlled cohort studies with prospective outcome-measurement evaluating the long-term consequences of PEP on endo- and exocrine pancreatic function (Study IV) and health related quality of life (HRQOL), performance status, and work capacity (Study V). A total of 78 subjects were included from a Danish cohort of patients undergoing first-time ERCP; 29 cases and 49 controls. Mean follow-up time was 5 years. Cases represented patients who developed PEP and controls those who did not. Cases and controls were matched on indication for ERCP, sex, age, and ASA-score.
In study IV pancreatic function was evaluated by blood-levels of hemoglobin A1c, C-peptide, vitamin B12, vitamin D, fecal elastase-1 test, and indirectly by changes in patient body weight over time. Results from study IV revealed no significant differences in pancreatic function parameters between cases and controls and severity of PEP was not associated with subsequent pancreatic function. Overall, body mass index, alcohol consumption, age, and smoking were associated with a compromised pancreatic function.
In Study V, HRQOL was evaluated by the short-form 36 questionnaire, performance status by the Zubrod score, and work capacity by categorizing the participants employment status. PEP was associated with a clinically significant, reduced, long-term mental HRQOL emotional-role score. Furthermore, reduced performance score and work capacity were significantly more frequent in cases as compared to matched controls. Overall, smoking, increasing age, female sex, and increasing body weight during follow-up were associated with reduced HRQOL-scores.
... From the Greek roots "pan" (all) and "kreas" (flesh or meat), the term "pancreas" was first coined by Ruphos of Ephesus (c. 100 CE), to describe an organ that had no cartilage or bone. Despite its early roots, it was not until much later that the first clinical description of acute pancreatitis by Nicholaes Tulp (1593-1674), a Dutch anatomist, was published [1]. However, amidst much speculation of causality, the first systematic assessment of acute pancreatitis was authored by Reginald Fitz in his entitled review "Acute Pancreatitis: A Consideration of Hemorrhage, Hemorrhagic, Suppurative, and Gangrenous Pancreatitis, and of Disseminated Fat Necrosis," highlighting alcohol, gallstones, and other etiologic factors. ...
Acute pancreatitis represents a disorder characterized by acute necroinflammatory changes of the pancreas and is histologically characterized by acinar cell destruction. Diagnosed clinically with the Revised Atlanta Criteria, and with alcohol and cholelithiasis/choledocholithiasis as the two most prominent antecedents, acute pancreatitis ranks first amongst gastrointestinal diagnoses requiring admission and 21st amongst all diagnoses requiring hospitalization with estimated costs approximating 2.6 billion dollars annually. Complications arising from acute pancreatitis follow a progression from pancreatic/peripancreatic fluid collections to pseudocysts and from pancreatic/peripancreatic necrosis to walled-off necrosis that typically occur over the course of a 4-week interval. Treatment relies heavily on fluid resuscitation and nutrition with advanced endoscopic techniques and cholecystectomy utilized in the setting of gallstone pancreatitis. When necessity dictates a drainage procedure (persistent abdominal pain, gastric or duodenal outlet obstruction, biliary obstruction, and infection), an endoscopic ultrasound with advanced endoscopic techniques and technology rather than surgical intervention is increasingly being utilized to manage symptomatic pseudocysts and walled-off pancreatic necrosis by performing a cystogastrostomy.
... The incidence of acute pancreatitis in children, like in adults, has been on the rise but acute pancreatitis has been clinically described since 1652. Dutch anatomist Tulp first described a young man with a suppurated pancreas on autopsy who presented with "continuous fever", severe abdominal pain that "he had no possibility of lying down" and "was tortured to death by this agony in such a miserable way", "against whose incessant attacks even Hercules could not have stood" [4][5][6]. This clinical scenario summarizes very well the presentation of acute pancreatitis. ...
... Acute pancreatitis (AP) is a potentially severe disease with an overall mortality up to 6% (de Beaux et al. 1995;Gislason et al. 2004), and increases the risk of developing pancreatic cancer (Munigala et al. 2014). Even though we have known about AP for over 350 years, its pathogenesis is still debated and there is no specific treatment (Pannala et al. 2009;Takacs et al. 2013). Bile acids and gallstones have long been implicated in the pathogenesis of AP (Opie, 1901). ...
Key points
Acute biliary pancreatitis is a sudden and severe condition initiated by bile reflux into the pancreas.
Bile acids are known to induce Ca²⁺ signals and necrosis in isolated pancreatic acinar cells but the effects of bile acids on stellate cells are unexplored.
Here we show that cholate and taurocholate elicit more dramatic Ca²⁺ signals and necrosis in stellate cells compared to the adjacent acinar cells in pancreatic lobules; whereas taurolithocholic acid 3‐sulfate primarily affects acinar cells.
Ca²⁺ signals and necrosis are strongly dependent on extracellular Ca²⁺ as well as Na⁺; and Na⁺‐dependent transport plays an important role in the overall bile acid uptake in pancreatic stellate cells.
Bile acid‐mediated pancreatic damage can be further escalated by bradykinin‐induced signals in stellate cells and thus killing of stellate cells by bile acids might have important implications in acute biliary pancreatitis.
Abstract
Acute biliary pancreatitis, caused by bile reflux into the pancreas, is a serious condition characterised by premature activation of digestive enzymes within acinar cells, followed by necrosis and inflammation. Bile acids are known to induce pathological Ca²⁺ signals and necrosis in acinar cells. However, bile acid‐elicited signalling events in stellate cells remain unexplored. This is the first study to demonstrate the pathophysiological effects of bile acids on stellate cells in two experimental models: ex vivo (mouse pancreatic lobules) and in vitro (human cells). Sodium cholate and taurocholate induced cytosolic Ca²⁺ elevations in stellate cells, larger than those elicited simultaneously in the neighbouring acinar cells. In contrast, taurolithocholic acid 3‐sulfate (TLC‐S), known to induce Ca²⁺ oscillations in acinar cells, had only minor effects on stellate cells in lobules. The dependence of the Ca²⁺ signals on extracellular Na⁺ and the presence of sodium–taurocholate cotransporting polypeptide (NTCP) indicate a Na⁺‐dependent bile acid uptake mechanism in stellate cells. Bile acid treatment caused necrosis predominantly in stellate cells, which was abolished by removal of extracellular Ca²⁺ and significantly reduced in the absence of Na⁺, showing that bile‐dependent cell death was a downstream event of Ca²⁺ signals. Finally, combined application of TLC‐S and the inflammatory mediator bradykinin caused more extensive necrosis in both stellate and acinar cells than TLC‐S alone. Our findings shed new light on the mechanism by which bile acids promote pancreatic pathology. This involves not only signalling in acinar cells but also in stellate cells.